TKM-100802

· Arbutus Biopharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TKM-100802, covering 2015-08-07 to 2015-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802 [Phase 1]